Lazard Asset Management »

Avita Therapeutics shares owned by Lazard Asset Management

Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Lazard Asset Management from 13F filings

Historical chart of Lazard Asset Management investment in Avita Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avita Therapeutics held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avita Therapeutics by Lazard Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.0k 128 7.81
2024-03-31 $87k 5.4k 16.03
2023-12-31 $79k 5.8k 13.58
2023-09-30 $79k 5.4k 14.60
2023-06-30 $92k 5.4k 17.01
2023-03-31 $38k 2.8k 13.73
2021-09-30 $65k 3.7k 17.45